E-DRUG: UU-WHO summer course programme in Utrecht, the Netherlands
-------------------------------------------------------------------------------------------------------
Dear E-Druggers,
This summer, the Division of Pharmacoepidemiology and Clinical Pharmacology at
Utrecht University, the Netherlands (the WHO CC for Pharmaceutical Policy and
Regulation), offers you again three challenging international summer courses:
6-10 July 2015 - Pharmacoepidemiology & Drug safety
13-17 July 2015 - Pharmaceutical Policy Analysis (in collaboration with WHO)
20-24 July 2015 - Pharmacoeconomics
More detailed information can be found below and on the summer school website
<http://www.utrechtsummerschool.nl>
All courses will cover the key issues in each field and focus on the most
important research methods used. All course teachers have extensive expertise
in their field.
A few scholarships are available for the Pharmaceutical Policy Analysis course.
These scholarships include course fee, basic student housing as described on
the summer school website and a small daily allowance to cover expenses for
food and local transport. International travel is at the expense of the
applicant or his/her institution.
If you wish to apply for a scholarship, please do so before 20 April 2015 by
sending an application letter including motivation plus CV to our course
assistant Winnie de Bruijn
<pharm.summercourses@gmail.com>
All applicants will be notified by 1 May 2015.
Supplementary, there is a cultural and social programme arranged for
participants to make sure that they experience the best of Utrecht.
Please feel free to share this information with others who might be interested
to attend. We look forward to welcoming you or them in Utrecht this summer!
Warm wishes,
Aukje Mantel,
Managing Director WHO CC for Pharmaceutical Policy & Regulation
M7 Pharmaceutical Policy Analysis (13-17 July 2015)
Medicines are among the most regulated products in society. From the earliest
pre-clinical stages onward, policy makers want to foster the development of
safe, effective and affordable medicines for patients in need of
pharmacotherapy. When a drug reaches the market, it is the beginning of a
process of complex interactions between patients, prescribers, insurers,
pharmaceutical companies and governments. Furthermore, the inequity in access
to medicines is still a defining characteristic of the global pharmaceutical
market place.
The aim of the course is to give students insight into current developments in
pharmaceutical policy making as well to give a better understanding of the
methods available for analysing the effects of policy interventions. As a
collaborator on this course, the World Health Organization will provide faculty
for several of the sessions.
You will experience an intensive programme covering the following topics:
Pharmaceutical Policy Analysis issues and methods; current challenges in drug
innovation; universal health coverage; regulatory issues and challenges;
country profiles; policy and politics; synthesis, case studies & public health
Course directors: Prof. Dr. Bert Leufkens, Dr. Kees de Joncheere (World Health
Organization) and Dr. Aukje Mantel.
M8 Pharmacoepidemiology & Drug Safety (6-10 July 2015)
With the prospect that innovative drug therapies will be introduced in the
coming years, society demands new approaches and concepts for comparative
risk/benefit evaluation. Assessment of safety and risk management of different
drug therapies is done in the framework of observational epidemiological
studies (proof of ‘safety’, proof of ‘effectiveness’). This is the logical next
step after randomized clinical trials, which are designed to provide evidence
of a drugs ‘efficacy’.
The course will cover key issues in pharmacoepidemiologic and drug safety
research. Special topics include databases and molecular pharmacoepidemiology.
Students will learn about the typical problems (e.g. confounding by indication,
rare side effects) and approaches to deal with these problems in the practice
of pharmacoepidemiology.
You will experience an intensive programme covering the following topics: Study
Design and Methods; Confounding and other biases; Methods in drug safety
research; Drug Safety and Risk Management; Overview of Pharmacoepidemiological
databases; Molecular Pharmacoepidemiology; Drug utilization research;
Synthesis, case studies & public health
Course directors: Prof. dr. O.H. Klungel and Prof. dr. T.P. van Staa
M14 Pharmacoeconomics (20-24 July 2015)
Today's society is confronted with ever increasing health care costs. One of
the factors is the cost of drug innovations. Diseases waiting for therapeutic
solutions are complicated and multifactorial in nature. As a result, drug
innovation has become even more complex leading to high tech and therefore high
cost solutions. The question arises, what is the added value of such high cost
innovations and how can it be determined when both benefit and harm are
considered. Health economics, and more specific pharmacoeconomics, aims to
provide a neutral scientific approach to this challenge.
This course aims to provide a broad perspective of the field, including a
variety of subjects from views of the different stakeholders to more in depth
methodological approaches, illustrated with examples and exercises.
You will experience an intensive programme covering the following topics:
Pharmacoeconomic techniques; Study designs and methods; Critical appraisal of
pharmacoeconomic studies; The (im)possibilities of the use of HTA and
pharmacoeconomics in regulatory decisions; The economics of personalized
medicine
Course directors: Dr. A. Hovels, Dr. G.W.J. Frederix, Prof. dr. J.A.M.
Raaijmakers
General information for all courses
Target groups
(Post)graduates and professionals within governments, NGOs, industry,
universities with a basic knowledge public health/medicine who have an interest
in the policy aspects of pharmaceuticals, pharmacoepidemiology and/or
pharmacoeconomics.
Fee and combinations
€950,- per course (including course materials + lunches + course dinner,
excluding housing). Combination fee for two courses is €1500,- (excluding
housing), combination fee for all three courses combined is €1950,- (excluding
housing)
Deadline for application
1 June 2015, see
<http://www.utrechtsummerschool.nl>
(information re summer school, course registration and housing)
More information
Course assistant: Winnie de Bruijn
<pharm.summercourses@gmail.com>
Aukje Mantel-Teeuwisse, PhD
Director School of Pharmacy, Utrecht University
http://students.uu.nl/beta/farmacie-m.
Managing director WHO Collaborating Centre for Pharmaceutical Policy and
Regulation
<https://solismail.uu.nl/owa/redir.aspx?C=ba448a83a7cc4540b0c669454cab9c8b&URL=http%3a%2f%2fwww.pharmaceuticalpolicy.nl%2f>)
Division Pharmacoepidemiology & Clinical Pharmacology
PO Box 80 082 | 3508 TB Utrecht
The Netherlands | Tel: +31 6 22736017 or +31 30 253 7324 (secretariat)
Visiting address:
David de Wied building | Universiteitsweg 99 | 3584 CG Utrecht | the Netherlands
"Mantel-Teeuwisse, A.K. (Aukje)" <A.K.Mantel@uu.nl>
|